Determinants of non-disclosure to sexual partner among human immune virus infected adults on anti-retroviral therapy follow-up care at North Shewa zone public hospitals in Oromia Region, Ethiopia

Abstract

BackgroundHIV positive status non-disclosure to sexual partner remains a challenge for HIV prevention and control. It leads to poor adherence to antiretroviral treatment and a high risk of transmission. The purpose of this study was to assess the determinants of HIV-positive status non-disclosure to sexual partner. MethodsAn institutional based case control study was conducted among 378 (94 cases and 284 controls) HIV-infected adults on Follow-Up Care. For data entry and analysis, Epi data version 3.1 and SPSS version 25 was used. To identify factors associated with non-disclosure to sexual partner, bivariable and multivariable logistic regression analyses were performed. ResultA total of 369 study participants were interviewed (92 cases and 277 controls), yielding a response rate of 97.5 %. Male sex (AOR: 0.25, 95 % CI: 0.13–0.47), ART duration < 36 months (AOR: 2.13, 95 % CI: 1.14–4.01), WHO clinical staging one (AOR: 3.00, 95 % CI: 1.26–7.12), having more than one lifetime sexual partners (AOR: 0.46, 95 % CI: 0.22–0.95) and not seeing person publicly disclosed HIV status (AOR: 3.12, 95 % CI: 1.47–6.65) were determinants of non-disclosure to sexual partner. ConclusionMale sex, ART duration of < 36 months, WHO clinical staging one, having more than one lifetime sexual partner, and not seeing person publicly disclosed HIV status were determinantal to sexual partner disclosure. As a result, continuous HIV disclosure counseling is required for females, those in WHO clinical staging one, ART duration < 36 months, and those with only one lifetime sexual partner.